Summary of Classification and Labelling
Harmonised classification - Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation)
General Information
Index Number EC / List no.

EC: European Community number/ List no.: List number assigned by ECHA.

List Numbers are purely technical identifiers for processing a submission via REACH-IT. More information: https://echa.europa.eu/information-on-chemicals/registered-substances/information

CAS Number International Chemical Identification
015-011-00-6 231-633-2 7664-38-2 phosphoric acid ... %, orthophosphoric acid ... %

ATP Inserted / Updated: CLP00 This field indicates when an entry in Annex VI to CLP has been inserted and/or updated with an Adaptation to Technical Progress (ATP) to the CLP Regulation.
CLP Classification (Table 3)
Classification Labelling Specific Concentration limits, M-Factors, Acute Toxicity Estimates (ATE) Notes
Hazard Class and Category Code(s) Hazard Statement Code(s) Hazard Statement Code(s) Supplementary Hazard Statement Code(s) Pictograms, Signal Word Code(s)
Skin Corr. 1B H314 H314 GHS05
Dgr
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
Skin Corr. 1B; H314: C ≥ 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Note B

Signal Words Pictograms
Danger
GHS05
Corrosion
Seveso III Data
Disclaimer: Please note that some of the substances covered by the Seveso Directive can belong to more than one Seveso categories. It will be up to the users to decide whether their substance or mixture fall in one or in more of these classification categories depending on the tonnage bands and the concentrations.
Please also note that ECHA is not an authority for the Seveso Directive and that the Seveso categorisation below is provided for information only. The Seveso III Directive (Directive 2012/18/EU repealing Directive 96/82/EC (Seveso II) from 1 June 2015) is the only authentic legal reference and that the information in this inventory does not constitute legal advice. For further information on Seveso, please ask your national authority.

Seveso Data
Seveso Substance Seveso Categories
No
Notified classification and labelling
General Information
EC / List no.

EC: European Community number/ List no.: List number assigned by ECHA.

List Numbers are purely technical identifiers for processing a submission via REACH-IT. More information: https://echa.europa.eu/information-on-chemicals/registered-substances/information

Name CAS Number
The CAS number associated with this substance in the EC Inventory and/or REACH-IT is reported here. In some cases, e.g. for differently hydrated forms of the same substance, alternative CAS numbers have been notified. In those cases, the additional CAS numbers are published in the column “additional notified information” below.
231-633-2 Orthophosphoric acid 7664-38-2

Notified classification and labelling according to CLP criteria
Classification Labelling Specific Concentration limits, M-Factors Notes Classification affected by Impurities / Additives

This check appears when a notifier has indicated that an impurity or an additive present in the substance impacts the notified classification. ECHA cannot reveal the identity of the impurity/additive or determine the exact impact it has on the classification.

Additional Notified Information

State/form: The notified state/form of the substance for all notifications classifying in this manner is reported under this link. Additional CAS number(s): Occasionally, a notification contains a different CAS number than the one reported under the general information section above. In those cases, all different notified CAS numbers associated with the aggregated classification are reported under this link. IUPAC name(s): Publicly available IUPAC names from all notifications classifying in this manner are reported under this link.

Number of Notifiers

This number indicates how many companies notified this classification. All members of a REACH registration joint submission and all participants in a group of manufacturers/importers who notified are counted. The grouping is done automatically with no manual verification.

Joint Entries

This check appears when a classification comes from a lead dossier of a REACH registration joint submission. When a member submits a classification separately under Article 11(3) of REACH (opt-out), this classification is displayed separately and not marked as a joint entry.

Hazard Class and Category Code(s) Hazard Statement Code(s) Hazard Statement Code(s) Supplementary Hazard Statement Code(s) Pictograms, Signal Word Code(s)
Met. Corr. 1 H290 H290 GHS05
GHS07
Dgr
Skin Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Note B
State/Form
IUPAC Names
104 yes View details
Acute Tox. 4 H302 H302
Skin Corr. 1B H314 H314
Eye Dam. 1 H318  
Met. Corr. 1 H290 H290 GHS05
Dgr
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Note B
State/Form
IUPAC Names
36 yes View details
Skin Corr. 1B H314 H314
Skin Corr. 1B H314 H314 GHS05
Dgr
Skin Irrit. 2; : 10 % ≤ C < 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Note B
State/Form
IUPAC Names
1033 View details
Skin Corr. 1B H314 H314 GHS05
Dgr
Note C
State/Form
IUPAC Names
747 View details
Met. Corr. 1 H290 H290 GHS05
GHS07
Dgr
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
State/Form
IUPAC Names
401 View details
Acute Tox. 4 H302 H302
Skin Corr. 1B H314 H314
Eye Dam. 1 H318 H318
Skin Corr. 1B H314 H314 GHS05
Dgr
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
State/Form
IUPAC Names
224 View details
Skin Corr. 1B H314 H314 GHS05
Dgr
State/Form
IUPAC Names
79 View details
Met. Corr. 1 H290 H290 GHS05
Dgr
State/Form
IUPAC Names
75 View details
Skin Corr. 1B H314 H314
Met. Corr. 1 H290 H290 GHS05
GHS07
Dgr
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
State/Form
IUPAC Names
66 View details
Acute Tox. 4 H312 H312
Skin Corr. 1B H314 H314
Eye Dam. 1 H318 H318
Skin Corr. 1B H314 H314 GHS05
Dgr
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C > 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Note B
State/Form
47 View details
Skin Corr. 1B H314 H314 GHS05
Dgr
45 View details
Eye Dam. 1 H318 H318
Acute Tox. 4 H302 H302 GHS05
GHS07
Dgr
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
State/Form
IUPAC Names
39 View details
Skin Corr. 1B H314 H314
Met. Corr. 1 H290 H290 GHS05
Dgr
State/Form
IUPAC Names
35 View details
Skin Corr. 1B H314 H314
Eye Dam. 1 H318 H318
Met. Corr. 1 H290 H290 GHS05
GHS07
Dgr
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
State/Form
IUPAC Names
35 View details
Acute Tox. 4 H302 H302
Skin Corr. 1B H314 H314
Skin Corr. 1B H314 H314 GHS05
Dgr
Skin Corr. 1C; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
34 View details
Met. Corr. 1 H290 H290 GHS05
Dgr
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
State/Form
IUPAC Names
27 View details
Skin Corr. 1B H314 H314
Met. Corr. 1 H290 H290 GHS05
GHS07
Dgr
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
State/Form
IUPAC Names
25 View details
Acute Tox. 4 H302 H302
Skin Corr. 1B H314 H314
Eye Dam. 1 H318  
  H314 Dgr
Skin Irrit. 2; : 10 % ≤ C < 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
24 View details
Met. Corr. 1 H290 H290 GHS05
GHS07
Dgr
State/Form
IUPAC Names
22 View details
Acute Tox. 4 H302 H302
Skin Corr. 1B H314 H314
Eye Dam. 1 H318  
Skin Corr. 1B H314 H314 GHS05
Dgr
Skin Irrit. 2; : 10 % ≤ C ≤ 25 %
State/Form
IUPAC Names
18 View details
Met. Corr. 1 H290 H290 GHS05
Dgr
15 View details
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
Skin Corr. 1B H314 H314 GHS05
Dgr
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : C ≥ 10 %
Note B
10 View details
Skin Corr. 1B H314 H314 GHS05
Dgr
Note B
State/Form
IUPAC Names
9 View details
Skin Corr. 1B H314 H314 GHS05
Dgr
Eye Irrit. 2; : C ≥ 10 %
Skin Irrit. 2; : C ≥ 10 %
Skin Corr. 1B; : C ≥ 25 %
Note B
State/Form
8 View details
Skin Corr. 1B H314 H314 GHS05
Dgr
Skin Irrit. 2; : 10 % ≤ C ≤ 25 %
Eye Irrit. 2; : 10 % ≤ C ≤ 25 %
Skin Corr. 1B; : 25 % ≤ C ≤ 100 %
Note B
IUPAC Names 7 View details
  H314 GHS05
Dgr
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
5 View details
  H318
Skin Corr. 1B H314 H314 GHS05
Dgr
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Note B
yes State/Form
IUPAC Names
5 View details
Skin Corr. 1B H314 H314 (H314) GHS05
Dgr
Note B
IUPAC Names 4 View details
Not Classified               4  
Acute Tox. 4 H302 H302 GHS05
GHS07
Dgr
4 View details
Skin Corr. 1B H314 H314
Eye Dam. 1 H318 H318
Skin Corr. 1B H314 H314 GHS05
Dgr
Skin Corr. 1C; : 25 % ≤ C < 100 %
Skin Corr. 1B; : 25 % ≤ C < 100 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Eye Dam. 1; : 25 % ≤ C < 100 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Note B
2 View details
Eye Dam. 1 H318  
Skin Corr. 1B H314 H314 Dgr
State/Form
2 View details
Met. Corr. 1 H290 H290 GHS05
Dgr
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : C ≥ 10 %
Skin Irrit. 2; : C ≥ 10 %
Note B
State/Form
2 View details
Skin Corr. 1B H314 H314
  H314 GHS05
Dgr
State/Form
2 View details
Skin Corr. 1C H314 H314 GHS05
Dgr
2 View details
Met. Corr. 1 H290   GHS05
Dgr
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Note B
State/Form
IUPAC Names
2 View details
Skin Corr. 1B H314 H314
Met. Corr. 1 H290 H290 GHS05
Dgr
Skin Irrit. 2; : 10 % ≤ C < 25 %
Eye Dam. 1; : 25 % ≤ C ≤ 100 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : 25 % ≤ C ≤ 100 %
Note B
State/Form
IUPAC Names
1 View details
Skin Corr. 1B H314 H314
Eye Dam. 1 H318 H318
Skin Corr. 1B H314 H314 GHS05
Dgr
Skin Corr. 1B; : C > 25 %
Note B
State/Form
1 View details
Met. Corr. 1 H290 H290 GHS05
Dgr
Eye Irrit. 2; : 10 % ≤ C ≤ 25 %
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : 10 % ≤ C ≤ 25 %
State/Form
IUPAC Names
1 View details
Skin Corr. 1B H314 H314
Eye Dam. 1 H318  
Skin Corr. 1B H314 H314 GHS05
GHS07
Dgr
Skin Irrit. 2; : 10 % ≤ C < 25 %
Eye Dam. 1; : C ≥ 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
State/Form
IUPAC Names
1 View details
Eye Dam. 1 H318 H318
STOT SE 3 H335 (respiratory air...) (Inhalation) H335
Acute Tox. 4 H302 H302 GHS05
Dgr
State/Form
1 View details
Skin Corr. 1B H314 H314
Skin Corr. 1B H314 H314 GHS05
Dgr
1 View details
Eye Dam. 1 H318  
Acute Tox. 4 H302 H302 GHS05
Dgr
1 View details
Skin Corr. 1C H314 H314
Eye Dam. 1 H318 H318
STOT SE 3 H335 (data lacking) H335
Acute Tox. 4 H302 H302 GHS05
GHS07
Dgr
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Note B
State/Form
IUPAC Names
1 View details
Skin Corr. 1B H314 H314
Met. Corr. 1 H290 H290 GHS05
Dgr
Skin Irrit. 2; : 10 % ≤ C < 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Note B
State/Form
IUPAC Names
1 View details
Skin Corr. 1B H314 H314
Eye Dam. 1 H318  
Skin Irrit. 2 H315 H315 GHS05
Dgr
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Note B
IUPAC Names 1 View details
Eye Irrit. 2 H319 H319
Acute Tox. 4 H302 H302 GHS05
GHS07
Dgr
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
State/Form
IUPAC Names
1 View details
Skin Corr. 1B H314 H314
Eye Dam. 1 H318  
Skin Corr. 1B H314 H314 GHS05
Dgr
Skin Corr. 1B; : 25 % ≤ C < 100 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Note B
1 View details
Eye Irrit. 2 H319  
Skin Corr. 1B H314 H314 GHS05
Dgr
Skin Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : 25 % ≤ C ≤ 100 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
IUPAC Names 1 View details
Met. Corr. 1 H290 H290 Dgr
1 View details
Skin Corr. 1B H314 H314
  H290 GHS05
Dgr
Skin Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Note B
State/Form
IUPAC Names
1 View details
Skin Corr. 1B H314 H314
Met. Corr. 1 H290 H290 GHS05
GHS07
Dgr
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Note B
State/Form
IUPAC Names
1 View details
Skin Corr. 1B H314 H314
Eye Dam. 1 H318 H318
STOT SE 3 H335 (respiratory tra...) H335
Skin Corr. 1B H314 H314 GHS05
Dgr
Skin Corr. 1B; : C ≥ 25 %
Eye Irrit. 2; : C ≥ 10 %
Skin Irrit. 2; : C ≥ 10 %
State/Form
1 View details
Skin Corr. 1B H314 H314 GHS05
GHS07
Dgr
Skin Corr. 1B; : 25 % ≤ C ≤ 100 %
Skin Irrit. 2; : 10 % ≤ C ≤ 25 %
Eye Irrit. 2; : 10 % ≤ C ≤ 25 %
Note B
IUPAC Names 1 View details
Eye Irrit. 2 H319 H319
Met. Corr. 1 H290 H290 GHS05
Dgr
State/Form
1 View details
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
Acute Tox. 4 H302 H302 GHS05
GHS07
Dgr
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
IUPAC Names 1 View details
Skin Corr. 1B H314 H314
Eye Dam. 1 H318 H318
Met. Corr. 1 H290 H290 GHS05
Dgr
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
State/Form
IUPAC Names
1 View details
Skin Corr. 1B H314 H314
Eye Dam. 1 H318  
Met. Corr. 1 H290 H290 GHS05
Dgr
Skin Corr. 1B; : C ≥ 25 %
IUPAC Names 1 View details
Skin Corr. 1B H314 H314
Skin Irrit. 2 H315 H315 GHS07
Wng
Skin Irrit. 2; : 10 % ≤ C < 25 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : C ≥ 25 %
State/Form
IUPAC Names
1 View details
Eye Irrit. 2 H319 H319
Skin Corr. 1 H314 H314 GHS05
Dgr
Skin Corr. 1C; : 25 % ≤ C < 100 %
Skin Corr. 1; : 25 % ≤ C < 100 %
Eye Dam. 1; : 25 % ≤ C < 100 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : 25 % ≤ C < 100 %
IUPAC Names 1 View details
Eye Dam. 1 H318  
Skin Corr. 1B H314 H314 GHS05
Dgr
Eye Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1B; : 25 % ≤ C < 100 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1; : 25 % ≤ C < 100 %
Eye Dam. 1; : 25 % ≤ C < 100 %
Skin Corr. 1C; : 25 % ≤ C < 100 %
IUPAC Names 1 View details
Eye Dam. 1 H318  
Skin Corr. 1 H314 H314 GHS05
Dgr
Eye Dam. 1; : 25 % ≤ C < 100 %
Skin Irrit. 2; : 10 % ≤ C < 25 %
Skin Corr. 1C; : 25 % ≤ C < 100 %
Skin Corr. 1; : 25 % ≤ C < 100 %
Skin Corr. 1B; : 25 % ≤ C ≤ 100 %
Eye Irrit. 2; : 10 % ≤ C < 25 %
IUPAC Names 1 View details
Eye Dam. 1 H318  
Met. Corr. 1 H290 H290 GHS05
Dgr
Skin Corr. 1B; : C ≥ 25 %
Eye Dam. 1; : C ≥ 25 %
Met. Corr. 1; : C ≥ 20 %
IUPAC Names 1 View details
Skin Corr. 1B H314 H314
Eye Dam. 1 H318 H318

Number of Aggregated Notifications: 63